Finally, enrichment of miR‐1298‐5p in CSF exosomes significantly inhibits glioma progression by promoting the immunosuppressive effects of MDSCs and glioma through targeting SETD7 and MSH2.110. This evidence concerns the gene MSH2 and central nervous system cancer.